• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估药品与其相关生产系统之间相互作用的安全性影响的关键方面。

Essential Aspects in Assessing the Safety Impact of Interactions between a Drug Product and Its Associated Manufacturing System.

作者信息

Jenke Dennis

机构信息

Technology Resources Division, Baxter Healthcare Corporation, Round Lake, IL.

出版信息

PDA J Pharm Sci Technol. 2012 Jan-Feb;66(1):63-77. doi: 10.5731/pdajpst.2012.00742.

DOI:10.5731/pdajpst.2012.00742
PMID:22307663
Abstract

UNLABELLED

An emerging trend in the biotechnology industry is the utilization of plastic components in manufacturing systems for the production of an active pharmaceutical ingredient (API) or a finished drug product (FDP). If the API, the FDP, or any solution used to generate them (for example, process streams such as media, buffers, and the like) come in contact with a plastic at any time during the manufacturing process, there is the potential that substances leached from the plastic may accumulate in the API or FDP, affecting safety and/or efficacy. In this article the author develops a terminology that addresses process streams associated with the manufacturing process. Additionally, the article outlines the safety assessment process for manufacturing systems, specifically addressing the topics of risk management and the role of compendial testing. Finally, the proper use of vendor-supplied extractables information is considered.

LAY ABSTRACT

Manufacturing suites used to produce biopharmaceuticals can include components that are made out of plastics. Thus it is possible that substances could leach out of the plastics and into manufacturing solutions, and it is further possible that such leachables could accumulate in the pharmaceutical product. In this article, the author develops a terminology that addresses process streams associated with the manufacturing process. Additionally, the author proposes a process by which the impact on product safety of such leached substances can be assessed.

摘要

非标签说明

生物技术行业中一个新兴趋势是在用于生产活性药物成分(API)或成品药物(FDP)的制造系统中使用塑料部件。如果API、FDP或用于生产它们的任何溶液(例如,培养基、缓冲液等工艺流)在制造过程中的任何时候与塑料接触,那么从塑料中浸出的物质有可能在API或FDP中积累,从而影响安全性和/或有效性。在本文中,作者制定了一套术语,用于描述与制造过程相关的工艺流。此外,本文概述了制造系统的安全评估过程,特别讨论了风险管理主题和药典测试的作用。最后,考虑了供应商提供的可提取物信息的正确使用方法。

摘要

用于生产生物制药的制造车间可能包括由塑料制成的部件。因此,物质有可能从塑料中浸出并进入制造溶液,并且这种可浸出物进一步有可能在药品中积累。在本文中,作者制定了一套术语,用于描述与制造过程相关的工艺流。此外,作者提出了一个可以评估此类浸出物质对产品安全性影响的流程。

相似文献

1
Essential Aspects in Assessing the Safety Impact of Interactions between a Drug Product and Its Associated Manufacturing System.评估药品与其相关生产系统之间相互作用的安全性影响的关键方面。
PDA J Pharm Sci Technol. 2012 Jan-Feb;66(1):63-77. doi: 10.5731/pdajpst.2012.00742.
2
Development and Justification of a Risk Evaluation Matrix To Guide Chemical Testing Necessary To Select and Qualify Plastic Components Used in Production Systems for Pharmaceutical Products.
PDA J Pharm Sci Technol. 2015 Nov-Dec;69(6):677-712. doi: 10.5731/pdajpst.2015.01077.
3
Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.为生物科技产品创建一个全面的可提取物和可浸出物(E&L)计划。
PDA J Pharm Sci Technol. 2015 Sep-Oct;69(5):590-619. doi: 10.5731/pdajpst.2015.01073.
4
A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.一份与药品包装、给药、管理及生产系统中所用材料相关的可提取物安全性影响信息汇编。
PDA J Pharm Sci Technol. 2014 Sep-Oct;68(5):407-55. doi: 10.5731/pdajpst.2014.00995.
5
Application of Quality by Design (QbD) Principles to Extractables/Leachables Assessment. Establishing a Design Space for Terminally Sterilized Aqueous Drug Products Stored in a Plastic Packaging System.将质量源于设计(QbD)原则应用于可提取物/可浸出物评估。为储存在塑料包装系统中的最终灭菌水性药品建立设计空间。
PDA J Pharm Sci Technol. 2010 Nov-Dec;64(6):527-35.
6
An extractables/leachables strategy facilitated by collaboration between drug product vendors and plastic material/system suppliers.
PDA J Pharm Sci Technol. 2007 Jan-Feb;61(1):17-23.
7
A general strategy for the chemical aspects of the safety assessment of extractables and leachables in pharmaceutical drug products: the chemical assessment triad.药品中可提取物和可浸出物安全性评估化学方面的总体策略:化学评估三元组
PDA J Pharm Sci Technol. 2012 Mar-Apr;66(2):168-83. doi: 10.5731/pdajpst.2012.00855.
8
Proper Accounting for Surface Area to Solution Volume Ratios in Exaggerated Extractions.在夸张提取中正确考虑表面积与溶液体积比。
PDA J Pharm Sci Technol. 2017 May-Jun;71(3):225-233. doi: 10.5731/pdajpst.2016.007195. Epub 2017 Feb 14.
9
Materials in Manufacturing and Packaging Systems as Sources of Elemental Impurities in Packaged Drug Products: A Literature Review.制造和包装系统中的材料作为包装药品中元素杂质的来源:文献综述
PDA J Pharm Sci Technol. 2015;69(1):1-48. doi: 10.5731/pdajpst.2015.01005.
10
Accumulation of organic compounds leached from plastic materials used in biopharmaceutical process containers.
PDA J Pharm Sci Technol. 2007 Jul-Aug;61(4):286-302.

引用本文的文献

1
Effect of phase shift from corals to Zoantharia on reef fish assemblages.从珊瑚到群体海葵的相移对珊瑚礁鱼类群落的影响。
PLoS One. 2015 Jan 28;10(1):e0116944. doi: 10.1371/journal.pone.0116944. eCollection 2015.